July 12, 2022 Case Review: MMJ & OUD

The Health Federation of Philadelphia(HFP) serves as a keystone supporting a network of Community Health Centers as well as the broader base of public and private-sector organizations that deliver health and human services to vulnerable populations.

The Health Federation of Philadelphia

This case will review strategies for navigating MMJ and OUD through an substance use disorder lens with a focus on low barrier treatment.

<h2>Case Review: Medical Cannabis &amp; Opioid Use Disorder</h2><h3>Best practices of medical marijuana (MMJ) for the treatment of opioid use disorder (OUD) have not been widely discussed. In this case, we will review strategies for navigating MMJ and OUD through an substance use disorder lens with a focus on low barrier treatment.</h3>CME Program Code: 23257Presenter: Adam Lake, MD, FAAFP, FASAM, AAHIVS, FACMQ, CMQ<ul><li>Medical Director, Family Physician, Lancaster General Health Physicians - Comprehensive Care</li></ul>Target Audience: Physicians, Physician Assistants, and Certified Registered Nurse Practitioners who have completed the MAT waiver training and didactic training of the MAT Preceptor program.Learning Objectives: 1. Describe the certification of medical cannabis for patients who have OUD.FEE: There is no fee for this program. ACCREDITATION STATEMENT:This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Drexel University College of Medicine and the Health Federation of Philadelphia. The Drexel University College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.AMA CREDIT DESIGNATION STATEMENT: The Drexel University College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.AOA: This program is eligible for 1 credits in Category 2A of the American Osteopathic Association.FACULTY DISCLOSURE STATEMENT:It is the policy of Drexel University College of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational programs. Speakers at continuing medical education activities are required to disclose to the audience any relevant commercial interest (which is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients). Any conflicts of interest must be resolved prior to the presentation and announced to the audience. The intent of this disclosure is to allow participants to form their own judgments about the educational content of this activity and determine whether the speaker’s commercial interests influenced the presentation. In addition, speakers are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentation.FACULTY DISCLOSURE: Adam Lake, MD has nothing to disclose.CME PLANNING COMMITTEE DISCLOSURES: Jennifer Kolker, MPH, Jeffrey Hom, MD and Debra D’Alessandro, MPH have no commercial relationships to disclose. FUNDING ACKNOWLEDGMENT: This program is funded in part by the Philadelphia Department of Public Health.

July 12, 2022 Case Review: MMJ & OUD

More events from The Health Federation of Philadelphia

Discover more events from The Health Federation of Philadelphia, from Health to other experiences you might love.

July 12, 2022 Case Review: MMJ & OUD

More events from The Health Federation of Philadelphia

Discover more events from The Health Federation of Philadelphia, from Health to other experiences you might love.

You might also like...

Browse more events with different dates, prices, and formats to find your next great experience.